Biology subjects

Gasnier, B.

Publications and source records attributed to Gasnier, B..

3 recordsLinked to original sources

bioRxiv2026

Probing the interaction between the WDR41 7CD loop of the C9ORF72 complex and purified PQLC2

The lysosomal cationic amino acid transceptor PQLC2 integrates transport with receptor-like signaling roles by recruiting the C9ORF72/SMCR8/WDR41 (CSW) complex in response to cellular cationic amino acid depletion. CSW recruitment depends on the interaction of PQLC2 with a disordered loop (7CD loop) extending from the WDR41 {beta}-propeller. Defining the molecular basis of this interaction is therefore essential for understanding how PQLC2 connects cellular amino acid availability to downstream signaling. Here, we used site-directed electron paramagnetic resonance (EPR) spectroscopy to characterize the interaction between purified PQLC2 and a synthetic WDR41 7CD loop peptide containing a site-specific nitroxide spin label. Using a consensus mutagenesis strategy, we stabilized detergent-purified PQLC2 and found that it assembles as a homotrimer, similar to other PQ-loop transporters. EPR experiments demonstrated the direct and specific association of the 7CD loop with PQLC2, and highlighted the key role of the the central region of the 7CD loop to establish this interaction via conserved aromatic residues. Spin labels introduced at different positions further provided local structural and dynamic information of the 7CD loop upon PQLC2 binding. The data supports a model in which the central region of the loop is anchored within the cytosolic cavity of PQLC2, whereas the flanking regions, which are dispensable for binding, retain substantial conformational flexibility. Together, we provide a direct biochemical evidence for PQLC2/WDR41 7CD loop recognition, a step forward towards understanding the transceptor mechanism of PQLC2.

biochemistry↗

bioRxiv2026

Molecular basis of Salla Disease: R39C Mutation Effects on the Lysosomal Transporter Sialin

Salla disease is caused by a genetic mutation in sialin, a lysosomal membrane transporter, which exports sialic acid from lysosomes. Substrate translocation occurs via a rocker-switch mechanism that alternately exposes the substrate-binding site to the lysosomal lumen and the cytosol. The pathogenic mutation R39C found in most Salla disease patients decreases the lysosomal localisation and the transport activity. In this study, we used computational and mutagenesis approaches to elucidate the molecular effects of the R39C mutation. Using three-dimensional models of human sialin in the lumen-open (LO) and cytosol-open (CO) states combined with the mutagenesis of selected residues, we identify a critical "triplet" motif comprising R39, E194, and E262, which is associated with an ionic lock formed between K197 and D350 in the LO conformation. Molecular dynamics simulations suggest that the electrostatic triplet negatively modulates the ionic lock, and are consistent with a strengthened ionic lock in R39C sialin, potentially favouring the LO state. To assess the global effects of the R39C mutation, we computed dynamic cross-correlation matrices and identified correlation patterns consistent with an allosteric coupling between the ionic lock K197/D350 and the region surrounding the sialic acid binding site in wild-type sialin, whereas in the LO state of R39C sialin, this communication preferentially bypasses this region. Therefore, the R39C mutation may impede the LO to CO conformational transition required for sialic acid transport, providing a plausible mechanistic framework for the decreased transport activity, and possibly the decreased lysosomal localisation, observed in Salla disease. HighlightsO_LIThe R39 residue participates in an interaction triplet, which negatively regulates an ionic lock stabilising the lumen-open conformation C_LIO_LIThe R39C mutation is associated with a stronger ionic lock in the simulations, and may favour the lumen-open state C_LIO_LICorrelation network analysis suggests an allosteric coupling between the ionic lock and the region surrounding the sialic acid binding site C_LIO_LIThe R39C mutation alters the inferred allosteric coupling between the ionic lock and the region surrounding the sialic acid binding site C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=80 SRC="FIGDIR/small/719580v1_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@1bf7144org.highwire.dtl.DTLVardef@1a53ab8org.highwire.dtl.DTLVardef@b2249forg.highwire.dtl.DTLVardef@1827244_HPS_FORMAT_FIGEXP M_FIG C_FIG

biochemistry↗

bioRxiv2023

MFSD1 in complex with its accessory subunit GLMP functions as a general dipeptide uniporter in lysosomes

Lysosomal degradation of macromolecules in lysosomes produces diverse small metabolites exported by specific transporters for reuse in biosynthetic pathways. Here, we deorphanized the Major Facilitator Superfamily Domain Containing 1 (MFSD1) protein, which forms a tight complex with the Glycosylated Lysosomal Membrane Protein (GLMP) in the lysosomal membrane. Untargeted metabolomics analysis of MFSD1-deficient mouse lysosomes revealed an increase in cationic dipeptides. Purified MFSD1 selectively bound diverse dipeptides, while electrophysiological, isotope tracer, and fluorescence-based studies in Xenopus oocytes and proteoliposomes showed that MFSD1/GLMP acts as a uniporter for cationic and neutral dipeptides. Cryo-EM structure of the dipeptide-bound MFSD1/GLMP complex in outward-open conformation characterized the heterodimer interface and, in combination with molecular dynamics simulations, provided a structural basis for its selectivity towards diverse dipeptides. Together, our data identify MFSD1 as a general lysosomal dipeptide uniporter, providing an alternative route to recycle lysosomal proteolysis products when lysosomal amino acid exporters are overloaded.

biochemistry↗